Article

Do ObGyns think hormonal contraception should be offered over the counter?

• Read More

Clinical Review

COVID-19 during pregnancy: How would you proceed in this case of a novel and ominous emerging pathogen?

Author:

Patrick Duff, MD

• Read More

Clinical Review

Progesterone for preterm delivery prevention

Author:

Alex C. Vidaeff, MD, MPH

Three cases explore the questions of yay or nay and appropriate administration routes

Researchers have been studying the...

• Read More

Clinical Review

2020 Update on prenatal phenotyping

Author:

Rebecca M. Reimers, MD

Stephanie H. Guseh, MD

In prenatal phenotyping, understanding standardization of language, specific prenatal descriptions, and artificial intelligence...

• Read More

Clinical Review

Evaluating and managing the patient with nipple discharge

For patients with pathologic nipple discharge, order the appropriate imaging studies, perform image-guided biopsy if necessary, and refer to a...

• Read More

Clinical Review

The STD epidemic: Why we need to care about this escalating problem

Author:

Lisa B. Haddad, MD, MS, MPH

Melissa J. Kottke, MD, MPH, MBA

Sexually transmitted diseases have broad-reaching impact on women’s health and maternal-child health. ObGyn engagement in evidence-based...

• Read More

From the Editor

Prescribing aspirin to improve pregnancy outcomes: Expand the indications? Increase the dose?

Author:

Robert L. Barbieri, MD

• Read More

Expert Commentary

Can a drug FDA approved for endometriosis become a mainstay for nonsurgical treatment of HMB in women with fibroids?

Author:

Steven R. Goldstein, MD

Elagolix is a GnRH antagonist that is approved in a 2-dose schedule for treatment of endometriosis. It is given...

• Read More

News for Your Practice

ACOG offers guidance on optimizing patient care in the midst of COVID-19

Author:

Andrew M. Kaunitz, MD

• Read More